Innovative Strategies for Addressing Hepatitis C in Indian Country March 14, 2016.

Slides:



Advertisements
Similar presentations
Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
Advertisements

The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
Hepatitis B: Epidemiology
Hepatitis C In Alaska’s Department of Corrections
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
What is hepatitis B? Hepatitis B is a virus that infects the liver.
Theresa L. Henry, Director of Field Services Program Integration The Virginia Experience Virginia Department of Health Division of Disease Prevention.
The Swiss Population In 2001 Resident population: 7,258,500 Population density: 176 per Km 2 Foreign nationals: 20.1% (~1,460,000) Excess of births over.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Pennsylvania: The State of HCV 2015
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
OVERVIEW OF PROJECT INSPIRE NYC Marie Bresnahan, MPH Project Director May 20,
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Making Every Contact Count Sarah McCormack 20 th October, 2015.
Bringing Hepatitis C Treatment into the Medical Home A Pilot Program for Drug Users Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission.
Hepatitis C: Where are we? Where do we want to go?
Epidemiology of HIV Among Men in Florida, Reported through 2011 Florida Department of Health HIV/AIDS & Hepatitis Program Annual data as of 12/31/2011.
From discovery to cure in 25 years -- the Hepatitis C story Mel Krajden MD, FRCPC Medical Head, Hepatitis Acting Medical Director, Public Health Laboratory.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
What is the contribution of alcohol to liver disease in the hepatitis C infected population. The epidemiological evidence Hamish Innes Research Fellow.
Role of Ministry of Health and Medical Education in management and control of Hepatitis C 2016/07/13.
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade.
Federal Welcome: A View from the Office of HIV/AIDS and
HCV Elimination Is it possible?.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
An Overview for Healthcare Providers
Hepatitis C Surveillance: From nothing to something...
Addressing Viral Hepatitis
Ladies and gentlemen, On behalf of my country, the Republic of Côte d’Ivoire, I want to tell you how very pleased I am to be part of this high-level meeting,
Cherokee Nation HCV Program: From Evaluation to Cure to Elimination
An Overview for Healthcare Providers
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Hepatitis C Allies of Philadelphia August 2, 2017
Cascade of care for persons newly diagnosed
Hepatitis C Incidence and Prevalence in the U.S.
HIV Care Continuum in Manhattan
Young People Newly Diagnosed with Hepatitis C in New York City
Cherokee Nation Health Services HCV Elimination Program
Lesson 3: The HCV Care Continuum
This is an archived document.
HIV-associated TB mortality and blocks in the cascade
Novel approaches to TB infection control in private general hospitals in Georgia T Gabunia1, I Khonelidze, N Solomonia, T Merabishvili, M Makharadze,
Building a Data Driven HCV Screening and Linkage-to-Care Program
Establishing a Pharmacy Managed HCV Service
Jonathan Mermin, MD, MPH RADM, USPHS
Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D
HCV: Who Should We Screen and Why?
DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
HCV Screening.
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
HCV epi overview Brigg Reilley, NPAIHB,
Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018
Hepatitis C Virus Diagnosis and the Holy Grail
Lesson 3: The HCV Care Continuum
Hepatitis C case-finding – An opportunity for community pharmacy
Managing Hepatitis C in Vermont
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Innovative Strategies for Addressing Hepatitis C in Indian Country March 14, 2016

JESSICA LESTON, MPH PROGRAMS MANAGER Hepatitis C in Indian Country Overview – Focus – Need

HCV Deaths and Deaths from Other Nationally Notifiable Infectious Diseases,* * TB, HIV, Hepatitis B and 57 other infectious conditions reported to CDC Holmberg S, et al. “Continued Rising Mortality from Hepatitis C Virus in the United States, ” Presented at ID Week 2015, October 10, 2015, San Diego, CA

Source: National Notifiable Diseases Surveillance System (NNDSS) Incidence of Acute Hepatitis C, by Race/Ethnicity – United States,

A 300% Increase in Hepatitis C –related Hospitalization for AI/AN – Byrd KK, et al Pub Hlth Rep 2011

HCV – Related Mortality by Race/Ethnicity 2007 compared to 2011 Byrd KK, et al Pub Hlth Rep 2011

Good and Bad News The good news  Hepatitis C can be cured  Curing HCV reduces mortality and morbidity  Curing HCV reduces the risk of transmission The bad news  The HCV epidemic still remains invisible  Public/Medical providers/Policy makers  It is the infectious diseases with the highest mortality 1  Access to treatment is complicated Good news again  WE CAN CHANGE THIS Holmberg SD, et al ID Week 2015 San Diego Slide courtesy Dr. Jorge Mera, Cherokee Nation

HCV Cascade Chronic HCV Infection 3.5 million in United States Diagnosed and Aware Access to Primary Care Antibody Tested RNA Confirmed Case ManagementRNA Tested Workup Case ManagementConsultations Prescribed HCV Treatment Continued Consultation Drug Access Achieved SVR Successfully Treated and Cured Communication, Systems and Strategic Thinking, Conflict and Change Management

HCV Screening persons born , IHS ALL IHS highest SU: 72% mid 2016 Total8%10%25%32%42%

Best Practices EHR reminders Quick-picks and automation Standing orders Clear delegation Formal policy and training Leadership Partnership Access innovations  PCC leads, pharmacy  Teleconsultation

Preliminary Epidemiology of HCV in IHS “Barbell” epi curve split between newly diagnosed baby boomers with longstanding infection and younger newly infected youth Younger HCV patients believed to be predominately among injection use as per wider US (prescription and opioids) Boomer seroprevalence range from 2%-12% in SUs > 50% screening

Simple, Effective, but out of Reach?

Where do we WANT to go?

REdesigned response to HCV is necessary Structural issues – policy, funding, legislation  Cost of drugs  PAP successful, but require dedicated staff  State Medicaid programs with ‘flat’ encounter rate Organizational issue – leadership, relationships Provider issues – training and education Patient issues – access, knowledge Innovation – rigor of development, adaptability Ethical implications – health equity and social responsibility

LINGERING QUESTIONS? CONTACT ME AT: OR OR Thank you